Google Answers: Rbustnest of Data Exclusivity Protection for a drug in EU

View Question

Q: Rbustnest of Data Exclusivity Protection for a drug in EU ( No Answer, 0 Comments )

Question

Subject: Rbustnest of Data Exclusivity Protection for a drug in EU
Category: Health
Asked by: medmax-ga
List Price: $200.00

Posted: 12 Aug 2004 09:39 PDT
Expires: 31 Aug 2004 05:35 PDT
Question ID: 386979

In the Pharmaceutical Industry:

-How strong is the protection of a drug in Europe via "Data
Exclusivity" once the "Composition of Matter" patent has expired

-Are there any examples of drugs that have successfully used "Data
Exclusivity" to maintain market exclusivity in Europe once ther
"Composition of matter" patent had expired

Answer

There is no answer at this time.

Comments

There are no comments at this time.

Important Disclaimer: Answers and comments provided on Google Answers are general information, and are not intended to substitute for informed professional medical, psychiatric, psychological, tax, legal, investment, accounting, or other professional advice. Google does not endorse, and expressly disclaims liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in answers or comments. Please read carefully the Google Answers Terms of Service.

If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you.

Search Google Answers for

Google Home - Answers FAQ - Terms of Service - Privacy Policy